RecruitingPhase 3NCT06515184

Coenzyme Q10 for Gulf War Illness: A Replication Study

Sponsor

University of California, San Diego

Enrollment

192 participants

Start Date

Sep 13, 2024

Study Type

INTERVENTIONAL

Conditions

Gulf War Syndrome Persian Gulf Syndrome Mitochondrial Disorder, Respiratory Chain

Summary

The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called PharmaNord Bio-Quinone Active CoQ10 Gold 100mg, a drug called PharmaNord Bio-Quinone Active CoQ10 Gold 100mg, and others for people with gulf war syndrome, mitochondrial disorder, respiratory chain, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPharmaNord Bio-Quinone Active CoQ10 Gold 100mg

Each participant receives one softgel three times a day. Arm 1 receives one 100mg softgel and two placebo softgels per day. Because of the presence of the IND, the dropdown menu does not allow us to choose dietary supplement. The option "drug" was chosen as the closest permissible option.

DRUGPharmaNord Placebo

Each participant receives one softgel three times a day. Arm 3 receives three placebo softgels per day. Supplement is taken orally in divided doses, with the last softgel not close to bedtime. Because of the presence of the IND, the dropdown menu does not allow us to choose dietary supplement. The option "drug" was chosen as the closest permissible option.

DRUGPharmaNord Bio-Quinone Active CoQ10 Gold 100mg

Each participant receives one softgel three times a day. Arm 2 receives three 100mg softgels per day. Supplement is taken orally in divided doses, with the last softgel not close to bedtime. Because of the presence of the IND, the dropdown menu does not allow us to choose dietary supplement. The option "drug" was chosen as the closest permissible option.